Literature DB >> 25525832

Human mesenchymal stroma/stem cells exchange membrane proteins and alter functionality during interaction with different tumor cell lines.

Yuanyuan Yang1, Anna Otte, Ralf Hass.   

Abstract

To analyze effects of cellular interaction between human mesenchymal stroma/stem cells (MSC) and different cancer cells, direct co-cultures were performed and revealed significant growth stimulation of the tumor populations and a variety of protein exchanges. More than 90% of MCF-7 and primary human HBCEC699 breast cancer cells as well as NIH:OVCAR-3 ovarian adenocarcinoma cells acquired CD90 proteins during MSC co-culture, respectively. Furthermore, SK-OV-3 ovarian cancer cells progressively elevated CD105 and CD90 proteins in co-culture with MSC. Primary small cell hypercalcemic ovarian carcinoma cells (SCCOHT-1) demonstrated undetectable levels of CD73 and CD105; however, both proteins were significantly increased in the presence of MSC. This co-culture-mediated protein induction was also observed at transcriptional levels and changed functionality of SCCOHT-1 cells by an acquired capability to metabolize 5'cAMP. Moreover, exchange between tumor cells and MSC worked bidirectional, as undetectable expression of epithelial cell adhesion molecule (EpCAM) in MSC significantly increased after co-culture with SK-OV-3 or NIH:OVCAR-3 cells. In addition, a small population of chimeric/hybrid cells appeared in each MSC/tumor cell co-culture by spontaneous cell fusion. Immune fluorescence demonstrated nanotube structures and exosomes between MSC and tumor cells, whereas cytochalasin-D partially abolished the intercellular protein transfer. More detailed functional analysis of FACS-separated MSC and NIH:OVCAR-3 cells after co-culture revealed the acquisition of epithelial cell-specific properties by MSC, including increased gene expression for cytokeratins and epithelial-like differentiation factors. Vice versa, a variety of transcriptional regulatory genes were down-modulated in NIH:OVCAR-3 cells after co-culture with MSC. Together, these mutual cellular interactions contributed to functional alterations in MSC and tumor cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25525832      PMCID: PMC4425222          DOI: 10.1089/scd.2014.0413

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  62 in total

1.  In vitro differentiation of mesenchymal stem cells into mesangial cells when co-cultured with injured mesangial cells.

Authors:  Chee-Yin Wong; Eng-Lai Tan; Soon-Keng Cheong
Journal:  Cell Biol Int       Date:  2014-01-10       Impact factor: 3.612

2.  Co-culture induces mesenchymal stem cell differentiation and modulation of the degenerate human nucleus pulposus cell phenotype.

Authors:  Sandra Strassburg; Stephen M Richardson; Anthony J Freemont; Judith A Hoyland
Journal:  Regen Med       Date:  2010-09       Impact factor: 3.806

3.  Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling.

Authors:  J Luo; S Ok Lee; L Liang; C-K Huang; L Li; S Wen; C Chang
Journal:  Oncogene       Date:  2013-06-24       Impact factor: 9.867

4.  Human mesenchymal stem cells modulate allogeneic immune cell responses.

Authors:  Sudeepta Aggarwal; Mark F Pittenger
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

5.  mRNA expression of the angiogenesis markers VEGF and CD105 (endoglin) in human breast cancer.

Authors:  Francisco Gómez-Esquer; David Agudo; Fernando Martínez-Arribas; María-José Nuñez-Villar; José Schneider
Journal:  Anticancer Res       Date:  2004 May-Jun       Impact factor: 2.480

6.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

7.  Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC.

Authors:  Ralf Hass; Cornelia Kasper; Stefanie Böhm; Roland Jacobs
Journal:  Cell Commun Signal       Date:  2011-05-14       Impact factor: 5.712

Review 8.  The roles of mesenchymal stem cells in tumor inflammatory microenvironment.

Authors:  Zhao Sun; Shihua Wang; Robert Chunhua Zhao
Journal:  J Hematol Oncol       Date:  2014-02-06       Impact factor: 17.388

9.  Mesenchymal stem cells.

Authors:  A I Caplan
Journal:  J Orthop Res       Date:  1991-09       Impact factor: 3.494

10.  The perivascular niche regulates breast tumour dormancy.

Authors:  Cyrus M Ghajar; Héctor Peinado; Hidetoshi Mori; Irina R Matei; Kimberley J Evason; Hélène Brazier; Dena Almeida; Antonius Koller; Katherine A Hajjar; Didier Y R Stainier; Emily I Chen; David Lyden; Mina J Bissell
Journal:  Nat Cell Biol       Date:  2013-06-02       Impact factor: 28.824

View more
  36 in total

Review 1.  Cancer stem cells and exosome signaling.

Authors:  Bethany N Hannafon; Wei-Qun Ding
Journal:  Stem Cell Investig       Date:  2015-06-02

Review 2.  Targeting cancer stem cell pathways for cancer therapy.

Authors:  Liqun Yang; Pengfei Shi; Gaichao Zhao; Jie Xu; Wen Peng; Jiayi Zhang; Guanghui Zhang; Xiaowen Wang; Zhen Dong; Fei Chen; Hongjuan Cui
Journal:  Signal Transduct Target Ther       Date:  2020-02-07

Review 3.  Disagreements in the therapeutic use of mesenchymal stem cell-derived secretome.

Authors:  Ferenc Sipos; Györgyi Műzes
Journal:  World J Stem Cells       Date:  2022-06-26       Impact factor: 5.247

4.  The MSC-MCF-7 Duet Playing Tumor Vasculogenesis and Angiogenesis onto the Chick Embryo Chorioallantoic Membrane.

Authors:  Şerban ComŞa; Amalia-Raluca CeauȘu; Roxana Popescu; Simona SÂrb; Anca-Maria CÎmpean; Marius Raica
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

Review 5.  Trogocytosis between Non-Immune Cells for Cell Clearance, and among Immune-Related Cells for Modulating Immune Responses and Autoimmunity.

Authors:  Ko-Jen Li; Cheng-Han Wu; Cheng-Hsun Lu; Chieh-Yu Shen; Yu-Min Kuo; Chang-Youh Tsai; Song-Chou Hsieh; Chia-Li Yu
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

6.  Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop.

Authors:  Lan G Coffman; Yun-Jung Choi; Karen McLean; Benjamin L Allen; Marina Pasca di Magliano; Ronald J Buckanovich
Journal:  Oncotarget       Date:  2016-02-09

7.  Conditioned umbilical cord tissue provides a natural three-dimensional storage compartment as in vitro stem cell niche for human mesenchymal stroma/stem cells.

Authors:  Yuanyuan Yang; Catharina Melzer; Vesna Bucan; Juliane von der Ohe; Anna Otte; Ralf Hass
Journal:  Stem Cell Res Ther       Date:  2016-02-11       Impact factor: 6.832

8.  c-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations.

Authors:  Anna Otte; Finn Rauprich; Juliane von der Ohe; Yuanyuan Yang; Friedrich Kommoss; Friedrich Feuerhake; Peter Hillemanns; Ralf Hass
Journal:  Oncotarget       Date:  2015-10-13

9.  Tunneling nanotubes: an alternate route for propagation of the bystander effect following oncolytic viral infection.

Authors:  Justin Ady; Venugopal Thayanithy; Kelly Mojica; Phillip Wong; Joshua Carson; Prassanna Rao; Yuman Fong; Emil Lou
Journal:  Mol Ther Oncolytics       Date:  2016-12-07       Impact factor: 7.200

Review 10.  Mesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor Microenvironment.

Authors:  Alessandro Poggi; Massimo Giuliani
Journal:  Vaccines (Basel)       Date:  2016-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.